Goldman Sachs
VYNT

Goldman Sachs’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Goldman Sachs’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-77
Closed -$23K – 7245
2016
Q2 		$23K Buy
+77
New +$27.1K ﹤0.01% 6676
2014
Q4 		– Sell
-82
Closed -$111K – 7368
2014
Q3 		$111K Sell
82
-2
-2% -$2.87K ﹤0.01% 6532
2014
Q2 		$143K Buy
84
+1
+1% +$1.9K ﹤0.01% 6404
2014
Q1 		$188K Sell
83
-29
-26% -$74.2K ﹤0.01% 6121
2013
Q4 		$231K Buy
+112
New +$242K ﹤0.01% 5869

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.57B AUM 370.24% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $160M AUM 14.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return